Heavy Metals / Chelation
1. Root Cause Overview
Heavy metal toxicity results from the accumulation of toxic metals (lead, mercury, arsenic, cadmium, aluminium, nickel) in tissues, where they displace essential minerals, inhibit enzyme function, generate oxidative stress, and disrupt neurological, endocrine, and immune systems. Sources include dental amalgam (mercury), contaminated water (lead, arsenic), occupational exposure, certain fish (methylmercury), and contaminated supplements. Functional chelation support uses nutritional agents to enhance endogenous metal excretion; pharmaceutical chelation (DMSA, DMPS, EDTA) is reserved for confirmed toxicity.
2. Common Signs & Symptoms
- Neurological: brain fog, memory loss, peripheral neuropathy, tremors
- Fatigue and weakness disproportionate to activity
- Mood disturbances: irritability, depression, anxiety
- Kidney dysfunction (cadmium, lead, mercury)
- Hypertension (lead)
- Anaemia (lead displaces iron in haem synthesis)
- Immune dysregulation and autoimmunity
- Skin changes: pigmentation, keratosis (arsenic)
- GI symptoms: nausea, abdominal pain, metallic taste
- Elevated toxic metals on urine or blood testing
3. Labs to Consider
CBC/CMP/eGFR, ferritin/iron, minerals, toxic metal testing when appropriate; document exposure source.
Choose the lab option based on what you want to assess within this root cause.
Hair Elements
Doctor's Data
4. Clinical Priorities
Assess for possible sources and patterns of heavy metal exposure, including occupational, dietary, dental, water, and hobby-related exposures, before considering chelation. Confirm burden with appropriate testing based on clinical context, and support antioxidant status, bowel regularity, detox capacity, and mineral balance before any metal mobilisation strategy. Pharmaceutical chelation, when indicated, requires specialist supervision.
Where to Start: Top 2 Supplements
The only non-prescription heavy metal chelator with human RCT evidence (significant reduction in blood lead in children). Gentle, safe, and effective for lead, mercury, cadmium, and arsenic. Does not deplete essential minerals like pharmaceutical chelators. Ideal first-line nutritional chelation support.
Forms stable, biologically inert mercury-selenide complexes, directly neutralising mercury toxicity. Essential protective nutrient for anyone with mercury burden (amalgam, fish consumption). Also supports glutathione peroxidase — the key antioxidant enzyme during chelation.
5. Diet Strategy
Emphasise sulphur-rich foods (garlic, onions, cruciferous vegetables, eggs) to support endogenous chelation via glutathione and metallothionein. Ensure adequate zinc, selenium, and calcium intake — these compete with toxic metals for absorption. Chlorella and cilantro are traditional metal-binding foods. Avoid high-mercury fish (shark, swordfish, king mackerel, tilefish). Choose organic produce to reduce pesticide co-burden. Adequate fibre supports faecal metal excretion.
6. Lifestyle Strategy
Remove all identified sources of exposure (amalgam removal by biological dentist, water filtration, occupational protection). Sauna therapy (infrared preferred) supports metal excretion through sweat. Ensure regular bowel movements to prevent metal reabsorption. Avoid alcohol during chelation — it impairs liver detox capacity. Manage stress — cortisol increases gut permeability and metal absorption.
7. Supplement Strategy
Full supplement list below. See Section 4 (Clinical Priorities) for the recommended Top 2 starting supplements. Add additional supplements based on lab results and clinical response at 4–6 week reassessment.
| Supplement | Dosage | Indication | Evidence | Key Results | Example |
|---|---|---|---|---|---|
| Modified Citrus Pectin (PectaSol-C®) [1] Gas and bloating (20% of patients); generally well tolerated; avoid in bowel obstruction | 5 g TID (15 g/day total) | Heavy metal chelation (lead, mercury, cadmium, arsenic); gentle non-pharmaceutical binder | Human clinical trial (children with lead toxicity) | Significant decrease in blood serum lead levels in children with toxic lead levels over 28 days | EcoNugenics PectaSol-C |
| Chlorella (broken cell wall) [2] GI upset during initial use; detox reactions possible — start low; avoid in autoimmune thyroid disease | 3–6 g/day (build up gradually) | Heavy metal binding and excretion; mercury and lead chelation support | Animal and clinical studies | Reduced tissue accumulation of methylmercury and lead; enhanced faecal metal excretion | Sun Chlorella A |
| Alpha-Lipoic Acid (ALA) [3] Hypoglycaemia risk in diabetics; GI upset; caution — ALA can redistribute mercury if used without DMSA | 300–600 mg/day | Mercury and arsenic chelation support; glutathione regeneration; antioxidant protection during chelation | Animal studies | Reduced oxidative damage and lead-induced toxicity; enhanced antioxidant enzyme activity during metal exposure | Klaire Labs Alpha Lipoic Acid |
| Selenium (as selenomethionine) [4] Selenosis at doses >400 mcg/day (hair loss, nail brittleness, GI upset); do not exceed recommended dose | 200 mcg/day | Mercury antagonism (forms inert mercury-selenide complex); antioxidant defence | Mechanistic and observational studies | Selenium forms stable, biologically inert complexes with mercury; reduces mercury bioavailability and toxicity | Pure Encapsulations Selenium |
| Garlic Extract (Allicin-standardised) [5] GI upset, halitosis; anticoagulant interaction | 600–900 mg/day | Lead and mercury chelation support; sulphur-containing chelating compounds | Human clinical trial | Garlic was as effective as D-penicillamine for reducing blood lead levels with fewer side effects | Allimax 180 mg Allisure Powder |
| Silicon (Silica water — for aluminium toxicity) [6] Generally well tolerated; excess silicon rare | 1 L/day of silica-rich mineral water (≥35 mg Si/L) | Aluminium chelation and urinary excretion; cognitive protection | Human clinical trial | Significant reduction in urinary and serum aluminium levels; cognitive improvement in Alzheimer's patients | Spritzer or Volvic mineral water (high silica content) |
8. Safety Notes
Pharmaceutical chelation (DMSA, DMPS, EDTA) must only be performed by a trained physician with confirmed metal toxicity — inappropriate chelation can cause severe mineral depletion and organ damage. ALA should not be used as a standalone mercury chelator without DMSA — it can redistribute mercury to the brain. Always support antioxidant and mineral status during any chelation protocol. Monitor kidney function throughout. Refer for confirmed heavy metal toxicity.
9. Citations & References
- [1]Modified Citrus Pectin (PectaSol-C®)Zhao ZY, Liang L, Fan X, et al. The role of modified citrus pectin as an effective chelator of lead in children hospitalized with toxic lead levels. Altern Ther Health Med. 2008;14(4):34–38.View source
- [2]Chlorella (broken cell wall)Uchikawa T, Kumamoto Y, Maruyama I, Kumamoto S, Ando Y, Yasutake A. The enhanced elimination of tissue methylmercury in Parachlorella beijerinckii-fed mice. J Toxicol Sci. 2011;36(1):121–126.View source
- [3]Alpha-Lipoic Acid (ALA)Pande M, Flora SJS. Lead induced oxidative damage and its response to combined administration of α-lipoic acid and succimers in rats. Toxicology. 2002;177(2–3):187–196.View source
- [4]Selenium (as selenomethionine)Ralston NVC, Raymond LJ. Dietary selenium's protective effects against methylmercury toxicity. Toxicology. 2010;278(1):112–123.View source
- [5]Garlic Extract (Allicin-standardised)Kianoush S, Balali-Mood M, Mousavi SR, et al. Comparison of therapeutic effects of garlic and D-Penicillamine in patients with chronic occupational lead poisoning. Basic Clin Pharmacol Toxicol. 2012;110(5):476–481.View source
- [6]Silicon (Silica water — for aluminium toxicity)Davenward S, Bentham P, Wright J, et al. Silicon-rich mineral water as a non-invasive test of the 'aluminium hypothesis' in Alzheimer's disease. J Alzheimers Dis. 2013;33(2):423–430.View source
Ask AI About This Protocol
Related Mini-Training
12:18Functional Gastroenterology Quick Start
9:47SIBO: Causes, Testing & Treatment
10:15Anti-Inflammatory Nutrition